Show side menu

Design and development of experimental vaccine prototypes

Technological offer upon request serving private businesses and public institutions interested in designing and developing new vaccine prototypes for animal and human purposes.


  • Scientific consulting leading to design the most appropriate immunization strategy, adapted to the etiology of the pathogen and to the protective immune mechanisms.
  • In silico prediction of potential vaccine candidates, including epitope prediction (B and T).
  • Design and preparation of vaccine prototypes: from inactivated and attenuated vaccines to recombinant subunit vaccines.
  • Design and performance of in vivo studies: from safety and immunogenicity assays to efficacy studies in small and large animals.



  • Multidisciplinary team of researchers: from the basics to the field.
  • BSL3 infrastructures: controlled containment facilities.



  • New vaccine prototypes for large animals (commercial purposes).
  • Proof of concept and validation of candidates for new human vaccines.
  • Know how transfer.
  • Partnering as a Contract Research Organization (CRO) or for research projects.

Examples of previous achievements

  • Patent 200502296(9). Experimental vaccine against Haemophilus parasuis obtained by reverse vaccinology.
  • Patent P26002ES00. Characterization of specific CD8 T-cell epitopes from African swine fever virus with protective potential.
  • Experimental vaccine prototypes against: Porcine Respiratory and Reproductive Syndrome Virus, porcine circovirus type 2, classical swine fever virus, African swine fever virus, porcine and avian influenza Viruses, foot-and-mouth disease virus, Haemophilus parasuis, Mycobacterium spp, Gumboro, Rift Valley fever virus and many others.


Download all the services at IRTA-CReSA (PDF)

Revisa aquest camp

Revisa aquest camp

Revisa aquest camp

Your message has been sent succesfully
Unable to send, try again